Ras and Raf pathways in epidermis development and carcinogenesis

被引:0
|
作者
F Kern
T Niault
M Baccarini
机构
[1] University of Vienna,
[2] Center for Molecular Biology,undefined
[3] Max F. Perutz Laboratories,undefined
[4] Doktor-Bohr-Gasse 9,undefined
[5] Current address: Microbes and Host Barriers Group,undefined
[6] Inserm Avenir U604,undefined
[7] Institut Pasteur,undefined
[8] 25 Rue du Docteur Roux,undefined
[9] 75724 Paris Cedex 15,undefined
[10] France,undefined
来源
British Journal of Cancer | 2011年 / 104卷
关键词
Raf kinases; Ras pathway; epidermal development; carcinogenesis; differentiation therapy;
D O I
暂无
中图分类号
学科分类号
摘要
The epidermis is the outermost layer of the body and protects it from environmental insults. This crucial function is sustained by a continuous process of self-renewal involving the carefully balanced proliferation and differentiation of progenitor cells constantly replacing the mature cells at the surface of the epidermis. Genetic changes in the signalling pathways controlling keratinocyte proliferation and differentiation disrupt this balance and lead to pathological changes including carcinogenesis. This review discusses the role of Ras, an oncogene critically involved in the development of skin neoplasia, and its downstream effector Raf in epidermal homeostasis and tumourigenesis. In particular, we will focus on the recently established role of Raf-1 as the decisive element that, by restraining keratinocyte differentiation, allows the development and maintenance of Ras-driven tumours.
引用
收藏
页码:229 / 234
页数:5
相关论文
共 50 条
  • [41] RAS ONCOGENES AND CHEMICAL CARCINOGENESIS
    BARBACID, M
    ZARBL, H
    SUKUMAR, S
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1985, 21 (11): : 1369 - 1369
  • [42] The Ras/Raf/MEK/ERK signaling pathway and its role in the occurrence and development of HCC
    Li, Lei
    Zhao, Guo-Dong
    Shi, Zhe
    Qi, Li-Li
    Zhou, Li-Yuan
    Fu, Ze-Xian
    ONCOLOGY LETTERS, 2016, 12 (05) : 3045 - 3050
  • [43] Conditional expression of H-Ras and Raf1: Influence on tumor development
    Heimerdinger, CK
    Schiffer, IB
    Gebhard, S
    Baasner, S
    Gilbert, S
    Beckers, T
    Oesch, F
    Hengstler, JG
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2003, 367 : R149 - R149
  • [44] Mechanism of intrinsic hydrolysis in Ras and the effect of Raf on oncogenic Ras mutants
    Mattos, Carla
    Buhrman, Greg
    Kumar, Senthil
    Wink, Glenna
    FASEB JOURNAL, 2009, 23
  • [45] An intact Raf zinc finger is required for optimal binding to processed Ras and for Ras-dependent Raf activation in situ
    Luo, ZJ
    Diaz, B
    Marshall, MS
    Avruch, J
    MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (01) : 46 - 53
  • [46] Dependence on PI3K and RAS-RAF pathways drives the activity of the combination of RAD001 and RAF265, a novel inhibitor of the RAF-MAPK pathway
    Mordant, P.
    Leteur, C.
    Bourhis, J.
    Soria, J. C.
    Deutsch, E.
    EJC SUPPLEMENTS, 2008, 6 (12): : 103 - 103
  • [47] Global gene analysis identifying genes commonly regulated by the Ras/Raf/MEK and type I IFN pathways
    Komatsu, Y.
    Hirasawa, K.
    Christian, S. L.
    GENOMICS DATA, 2015, 4 : 84 - 87
  • [48] REQUIREMENT FOR RAS IN RAF ACTIVATION IS OVERCOME BY TARGETING RAF TO THE PLASMA-MEMBRANE
    LEEVERS, SJ
    PATERSON, HF
    MARSHALL, CJ
    NATURE, 1994, 369 (6479) : 411 - 414
  • [49] Ras and Calcium Signaling Pathways Converge at Raf1 via the Shoc2 Scaffold Protein
    Yoshiki, Sayaka
    Matsunaga-Udagawa, Rie
    Aoki, Kazuhiro
    Kamioka, Yuji
    Kiyokawa, Etsuko
    Matsuda, Michiyuki
    MOLECULAR BIOLOGY OF THE CELL, 2010, 21 (06) : 1088 - 1096
  • [50] Morphoproteomic profile of mTOR, Ras/Raf kinase/ERK, and NF-κB pathways in human gastric adenocarcinoma
    Feng, Wei
    Brown, Robert. E.
    Trung, Camtu D.
    Li, Wei
    Wang, Liwei
    Khoury, Thaer
    Alrawi, Sadir
    Yao, James
    Xia, Keping
    Tan, Dongfeng
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2008, 38 (03): : 195 - 209